BFM
SRPT icon

Boothbay Fund Management’s Sarepta Therapeutics SRPT Stock Holding History

Boothbay Fund Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,100
Closed -$272K – 1836
2024
Q1 		$272K Sell
2,100
-75,500
-97% -$9.25M 0.01% 1227
2023
Q4 		$7.48M Sell
77,600
-32,400
-29% -$3.11M 0.19% 107
2023
Q3 		$13.3M Buy
110,000
+85,600
+351% +$9.68M 0.32% 48
2023
Q2 		$2.79M Sell
24,400
-102,700
-81% -$13.2M 0.06% 426
2023
Q1 		$17.5M Buy
+127,100
New +$16.5M 0.36% 25
2021
Q2 		– Sell
-597
Closed -$4.45M – 2095
2021
Q1 		$4.45M Sell
597
-365
-38% -$33.7K 0.17% 119
2020
Q4 		$16.4M Buy
962
+367
+62% +$54.4K 0.61% 16
2020
Q3 		$8.36M Buy
+595
New +$90.4K 0.51% 19
2019
Q4 		– Sell
-73
Closed -$550K – 983
2019
Q3 		$550K Sell
73
-147
-67% -$17.4K 0.05% 437
2019
Q2 		$3.34M Sell
220
-108
-33% -$13.1K 0.3% 67
2019
Q1 		$3.91M Buy
328
+235
+253% +$30.2K 0.38% 57
2018
Q4 		$1.01M Sell
93
-253
-73% -$31.6K 0.15% 144
2018
Q3 		$5.59M Sell
346
-147
-30% -$20.1K 0.55% 34
2018
Q2 		$6.52M Buy
+493
New +$46.5K 0.57% 38
2016
Q2 		– Sell
-48,300
Closed -$943K – 595
2016
Q1 		$943K Buy
+48,300
New +$844K 0.7% 22

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Boothbay Fund Management's SRPT Position: Q3 2025 in Review

Boothbay Fund Management sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 153,460 shares — an estimated $2.74M sold.

Boothbay Fund Management first reported a position in SRPT in Q3 2016 and held it in 14 quarters. The position peaked at $9.06M in Q2 2024. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Boothbay Fund Management reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 153,460 Sarepta Therapeutics shares in Q3 2025, an estimated $2.74M.
  • Boothbay Fund Management first reported a position in Sarepta Therapeutics in Q3 2016 and held it in 14 quarters.
  • Boothbay Fund Management's Sarepta Therapeutics position peaked at $9.06M in Q2 2024.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.